About
Our Mission
Leadership
Partners
Our Technologies
TALEN® Technology
Gene Editing
PulseAgile Technology
Patents
Pipeline
Products
Clinical Indications
Manufacturing
Investors
Press Releases
Corporate presentation & ESG report
Scientific Presentations
Scientific Publications
Events and Webcasts
2021 Cellectis Innovation Days
Stock Information
Corporate Governance
Governance Documents
Board of Directors & Committee Members
Shareholders Meeting
SEC Filings
Contact
IR Inquiries
Email Alerts
Investor FAQ
Careers
Our Culture
Job Opportunities
Contact us
fr
Press Releases
Our latest news and press releases
Press releases
Corporate presentation
Scientific Presentations
Scientific Publications
Events and webcasts
Stock information
SEC filings
Financial Statements
Regulated information
Voting Rights & Share Capital
ATM Program
General meetings
Governance
The board and committee members
Corporate governance documents
FAQ
IR Inquiry
All
2025
2024
2023
2022
2021
2020
13
Mar 2025
18:15 E.S.T.
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update
Read more
07
Mar 2025
04:36 E.S.T.
Cellectis to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025
Read more
24
Feb 2025
01:30 E.S.T.
Cellectis Presents ‘Smart CAR T’ Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025
Read more
10
Dec 2024
14:50 E.S.T.
Cellectis announces the drawdown of the third tranche of €5 million under the credit facility agreement entered with the European Investment Bank (EIB)
Read more
05
Nov 2024
16:30 E.S.T.
Cellectis Presents Multiple Strategies to Enhance CAR T-cell Efficacy in Solid Tumors at the SITC Annual Meeting
Read more
04
Nov 2024
16:30 E.S.T.
Cellectis Provides Business Updates and Financial Results for Third Quarter 2024
Read more
1
2
3
Next